End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
66.78 CNY | +0.39% |
|
+4.41% | -42.48% |
Chart calendar Asymchem Laboratories (Tianjin) Co., Ltd.
Upcoming events on Asymchem Laboratories (Tianjin) Co., Ltd.
Past events on Asymchem Laboratories (Tianjin) Co., Ltd.
2024-06-06 02:00 am | Annual General Meeting |
2024-04-24 | Q1 2024 Earnings Release |
2024-03-27 | Q4 2023 Earnings Release |
2024-02-29 01:00 am | Extraordinary Shareholders Meeting |
2024-01-22 01:00 am | Extraordinary Shareholders Meeting |
2023-10-29 | Q3 2023 Earnings Release |
2023-10-18 02:00 am | Shareholders Meeting |
2023-08-28 | Q2 2023 Earnings Release |
2023-06-09 02:00 am | Annual General Meeting |
2023-04-27 | Q1 2023 Earnings Release |
2023-03-29 | Q4 2022 Earnings Release |
2022-12-16 01:00 am | Extraordinary Shareholders Meeting |
2022-10-28 02:00 am | Extraordinary Shareholders Meeting |
2022-10-26 | Q3 2022 Earnings Release |
2022-09-02 02:00 am | Extraordinary Shareholders Meeting |
2022-08-24 | Interim 2022 Earnings Release |
2022-06-09 02:00 am | Annual General Meeting |
2022-06-09 02:00 am | Shareholders Meeting |
2022-05-05 02:00 am | Extraordinary Shareholders Meeting |
2022-04-19 | Q1 2022 Earnings Release |
Past dividends on Asymchem Laboratories (Tianjin) Co., Ltd.
2024-06-27 | Annual 1.8 CNY |
2023-06-27 | Annual 1.8 CNY |
2022-07-20 | Annual 0.8 CNY |
2021-07-12 | Annual 0.6 CNY |
2020-06-23 | Annual 0.5 CNY |
2019-06-09 | Annual 0.4 CNY |
2018-05-24 | Annual 0.35 CNY |
2017-06-13 | Annual 0.5 CNY |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 2 460 2 454 0.23% | 3 150 3 165 -0.5% | 4 632 4 482 3.36% | 10 230 10 375 -1.4% | 7 825 8 480 -7.72% | 6 325 |
EBITDA Million CNY | Released Forecast Spread | 749 733 2.15% | 977 936 4.4% | 1 269 1 333 -4.83% | 3 498 3 481 0.48% | 3 058 2 904 5.3% | 1 596 |
EBIT Million CNY | Released Forecast Spread | 624 637 -2.06% | 817 850 -3.86% | 1 068 1 154 -7.49% | 3 136 3 137 -0.05% | 2 571 2 721 -5.53% | 1 276 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 624 643 -3.04% | 814 848 -3.97% | 1 193 1 166 2.32% | 3 725 3 565 4.49% | 2 557 2 842 -10.03% | 1 345 |
Net income Million CNY | Released Forecast Spread | 554 568 -2.45% | 722 749 -3.54% | 1 069 1 030 3.77% | 3 302 3 208 2.91% | 2 269 2 507 -9.49% | 1 273 |
EPS CNY | Released Forecast Spread | 1,71 1,75 -1.98% | 2,20 2,23 -1.29% | 3,14 2,91 7.72% | 9,00 8,73 3.03% | 6,26 6,86 -8.74% | 3,47 |
Announcement Date | 28/02/20 | 15/04/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 2 879 2 881 -0.08% | 5 034 4 306 16.91% | 2 770 2 749 0.78% | 5 198 5 217 -0.37% | 2 249 1 679 33.95% | 2 350 2 265 3.76% | 4 596 4 557 0.85% | 1 762 2 050 -14.08% | 1 481 1 838 -19.43% | 3 186 3 398 -6.26% | 1 400 1 867 -25.02% | 1 336 | 2 700 | 1 562 | 1 863 | 3 425 | 2 203 | 2 324 |
EBIT Million CNY | Released Forecast Spread | 711 696 2.06% | 1 699 1 069 58.97% | 1 464 1 571 -6.78% | 952 682 39.64% | 1 670 1 400 19.3% | 560 527 6.31% | 81,2 280 -70.99% | 565 791 -28.47% | 243 | 425 | 206 | 281 | 487 | |||||
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 560 831 -32.65% | 69,0 478 -85.56% | ||||||||||||||||
Net income Million CNY | Released Forecast Spread | 981 960 2.17% | 524 703 -25.5% | ||||||||||||||||
EPS CNY | Released Forecast Spread | 1,72 0,85 102.35% | |||||||||||||||||
Announcement Date | 30/03/22 | 25/08/22 | 27/10/22 | 30/03/23 | 28/04/23 | 29/08/23 | 29/08/23 | 30/10/23 | 28/03/24 | 28/03/24 | 25/04/24 | - | - | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Asymchem Laboratories (Tianjin) Co., Ltd.
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002821 Stock
- Calendar Asymchem Laboratories (Tianjin) Co., Ltd.